Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype

Autor: Von Massow, Georg, Garcia Cehic, Damir, Gregori Font, Josep, Rodríguez Frias, Francisco, Macià, María Dolores, Escarda, Ana, Esteban Mur, Juan Ignacio, Quer Sivila, Josep

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Infection and Drug Resistance
Scientia

Hepatitis C virus (HCV) is a highly variable infectious agent, classified into 8 genotypes and 86 subtypes. Our laboratory has implemented an in-house developed high-resolution HCV subtyping method based on next-generation sequencing (NGS) for error-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1c6f38d5751b0a3594333d4f41511946
https://ddd.uab.cat/record/222733

Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

Autor: De Gottardi, Andrea, Trebicka, Jonel, Klinger, Christoph, Plessier, Aurélie, Seijo, Susana, Terziroli, Benedetta, Magenta, Lorenzo, Semela, David, Buscarini, Elisabetta, Langlet, Philippe, Görtzen, Jan, Puente, Angela, Müllhaupt, Beat, Navascuès, Carmen, Nery, Filipe, Deltenre, Pierre, Turon, Fanny, Engelmann, Cornelius, Arya, Rupen, Caca, Karel, Peck‐Radosavljevic, Markus, Leebeek, Frank W. G., Valla, Dominique, Garcia‐Pagan, Juan Carlos, Grønbæk, Henning, Beer, Jürg‐Hans, Genescà, Joan, Hidalgo, Canete, Vila, Carmen, Mihailovic, Jelena, Piscaglia, Fabio, Lasser, Luc, Fernandez‐Bermejo, Miguel, Procopet, Bogdan, Schouten, Jeoffrey, Spahr, Laurent, Sanchez, José Louis, Zipprich, Alexander, Sekhar, Mallika, Hernandez‐Guerra, Manuel, Laguna, La, Nevens, Frederik, Ferreira, Carlos Noronha, Heneghan, Michael, Albillos, Agustin, Llop, Elba, Dell'Era, Alessandra, La Mura, Vincenzo, Primignani, Massimo, Senzolo, Marco, Escarda, Ana, Mallorca, Palma, Riggio, Oliviero, Murad, Sarwa Darwish, Haas, Stephan, Bureau, Christophe, Berenguer, Marina

Publikováno v: de Gottardi, A, Trebicka, J, Klinger, C, Plessier, A, Seijo, S, Terziroli, B, Magenta, L, Semela, D, Buscarini, E, Langlet, P, Görtzen, J, Puente, A, Müllhaupt, B, Navascuès, C, Nery, F, Deltenre, P, Turon, F, Engelmann, C, Arya, R, Caca, K, Peck-Radosavljevic, M, Leebeek, F W G, Valla, D, Garcia-Pagan, J C, VALDIG Investigators (Henning Grønbæk, member) & Grønbæk, H 2017, ' Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis ', Liver International, vol. 37, no. 5, pp. 694-699 . https://doi.org/10.1111/liv.13285
Liver International, 37(5), 694-699. Wiley-Blackwell Publishing Ltd
Liver International

BACKGROUND: Direct-acting oral anticoagulants (DOACs) are used in patients with splanchnic vein thrombosis (SVT) and cirrhosis, but evidence for safety and efficacy in this setting is limited. Our aim was to identify indications and reasons for start

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c65f07b4ac1e49a92d9337eaf9c5bb1b

Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype.

Autor: von Massow G; Liver Unit, Liver Diseases - Viral Hepatitis, Vall d'Hebron Institut of Research (VHIR) - Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain., Garcia-Cehic D; Liver Unit, Liver Diseases - Viral Hepatitis, Vall d'Hebron Institut of Research (VHIR) - Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain., Gregori J; Liver Unit, Liver Diseases - Viral Hepatitis, Vall d'Hebron Institut of Research (VHIR) - Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.; Roche Diagnostics S.L., Sant Cugat del Vallès, Barcelona, Spain., Rodriguez-Frias F; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.; Biochemistry and Microbiology Department, VHIR-HUVH, Barcelona, Spain., Macià MD; Unidad de Microbiología Molecular, Servicio de Microbiología, Instituto de Investigación Sanitaria de les Illes Balears (IdISBa), Hospital Universitario Son Espases, Mallorca, Spain., Escarda A; Digestive Department, Hospital Universitario Son Espases, Mallorca, Spain., Esteban JI; Liver Unit, Liver Diseases - Viral Hepatitis, Vall d'Hebron Institut of Research (VHIR) - Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.; Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain., Quer J; Liver Unit, Liver Diseases - Viral Hepatitis, Vall d'Hebron Institut of Research (VHIR) - Hospital Universitari Vall d'Hebron (HUVH), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.; Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain.

Publikováno v: Infection and drug resistance [Infect Drug Resist] 2019 Apr 24; Vol. 12, pp. 947-955. Date of Electronic Publication: 2019 Apr 24 (Print Publication: 2019).